Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devrim Cabuk

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Oncology|November 21, 2007
Vascular endothelial growth factor, hypoxia-inducible factor 1 alpha and CD34 expressions in early-stage gastric tumors: relationship with pathological factors and prognostic impact on survivalDevrim Cabuk, Gul Basaran, Cigdem Celikel, et al.
International Journal of Clinical and Experimental Medicine|July 5, 2014
Associations between clinicopathological prognostic factors and pAkt, pMAPK and topoisomerase II expression in breast cancerMehmet Salih Iyikesici, Gul Basaran, Faysal Dane, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|February 18, 2014
Clinical outcome of Turkish metastatic breast cancer patients with currently available treatment modalities--single center experienceDevrim Cabuk, Gul Basaran, Mehmet Teomete, et al.
Medical Oncology (Northwood, London, England)|March 23, 2010
Weight gain after adjuvant chemotherapy in patients with early breast cancer in Istanbul TurkeyGul Basaran, Nazım Serdar Turhal, Devrim Cabuk, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|June 4, 2013
XELIRI plus bevacizumab compared with FOLFIRI plus bevacizumab as first-line setting in patients with metastatic colorectal cancer: experiences at two-institutionsKazim Uygun, Ahmet Bilici, Serap Kaya, et al.
Medical Oncology (Northwood, London, England)|December 26, 2009
Pulmonary toxicity in patients receiving docetaxel chemotherapyPerran F Yumuk, Umut Kefeli, Berrin Ceyhan, et al.
Oncotargets and Therapy|December 31, 2014
Efficacy of sorafenib in advanced differentiated and medullary thyroid cancer: experience in a Turkish populationMustafa Benekli, Suayib Yalcin, Metin Ozkan, et al.
Bosnian Journal of Basic Medical Sciences|July 3, 2016
Impact of active smoking on survival of patients with metastatic lung adenocarcinoma harboring an epidermal growth factor receptor (EGFR) mutationBulent Erdogan, Hilmi Kodaz, Senem Karabulut, et al.
Medicine|November 28, 2023
Prognostic role of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, and pan-immune-inflammation value in metastatic castration-resistant prostate cancer patients who underwent 177Lu-PSMA-617Elif Şahin, Umut Kefeli, Şevket Zorlu, et al.
Annals of Human Genetics|December 8, 2022
The role of next-generation sequencing in the examination of signaling genes in Brca1/2-negative breast cancer casesNaci Cine, Cansu Ugurtas, Merve Gokbayrak, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Oncology|November 21, 2007
Vascular endothelial growth factor, hypoxia-inducible factor 1 alpha and CD34 expressions in early-stage gastric tumors: relationship with pathological factors and prognostic impact on survivalDevrim Cabuk, Gul Basaran, Cigdem Celikel, et al.
International Journal of Clinical and Experimental Medicine|July 5, 2014
Associations between clinicopathological prognostic factors and pAkt, pMAPK and topoisomerase II expression in breast cancerMehmet Salih Iyikesici, Gul Basaran, Faysal Dane, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|February 18, 2014
Clinical outcome of Turkish metastatic breast cancer patients with currently available treatment modalities--single center experienceDevrim Cabuk, Gul Basaran, Mehmet Teomete, et al.
Medical Oncology (Northwood, London, England)|March 23, 2010
Weight gain after adjuvant chemotherapy in patients with early breast cancer in Istanbul TurkeyGul Basaran, Nazım Serdar Turhal, Devrim Cabuk, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|June 4, 2013
XELIRI plus bevacizumab compared with FOLFIRI plus bevacizumab as first-line setting in patients with metastatic colorectal cancer: experiences at two-institutionsKazim Uygun, Ahmet Bilici, Serap Kaya, et al.
Medical Oncology (Northwood, London, England)|December 26, 2009
Pulmonary toxicity in patients receiving docetaxel chemotherapyPerran F Yumuk, Umut Kefeli, Berrin Ceyhan, et al.
Oncotargets and Therapy|December 31, 2014
Efficacy of sorafenib in advanced differentiated and medullary thyroid cancer: experience in a Turkish populationMustafa Benekli, Suayib Yalcin, Metin Ozkan, et al.
Bosnian Journal of Basic Medical Sciences|July 3, 2016
Impact of active smoking on survival of patients with metastatic lung adenocarcinoma harboring an epidermal growth factor receptor (EGFR) mutationBulent Erdogan, Hilmi Kodaz, Senem Karabulut, et al.
Medicine|November 28, 2023
Prognostic role of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, and pan-immune-inflammation value in metastatic castration-resistant prostate cancer patients who underwent 177Lu-PSMA-617Elif Şahin, Umut Kefeli, Şevket Zorlu, et al.
Annals of Human Genetics|December 8, 2022
The role of next-generation sequencing in the examination of signaling genes in Brca1/2-negative breast cancer casesNaci Cine, Cansu Ugurtas, Merve Gokbayrak, et al.
Pageof 4